Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | 0.00% | +9,900.00% | -99.71% |
2023 | ObsEva to Suspend Reporting With SEC Following Delisting From Nasdaq | MT |
2023 | ObsEva to Change Central Securities Depositary to SIX SIS; Shares Up 9% | MT |
Business Summary
Number of employees: 15
Sales per Business
CHF in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Women's Reproductive, Health and Pregnancy Therapeutics
100.0
%
| 0 | nan % | 19 | 100.0 % | - |
Sales per region
CHF in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Switzerland
100.0
%
| 0 | nan % | 19 | 100.0 % | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 146,919,237 | 103,079,787 ( 70.16 %) | 29,741,950 ( 20.24 %) | 70.16 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
OBSEVA SA 22.97% | 33,741,950 | 22.97% | 45,552 $ |
Company contact information
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
-99.71% | 11.72K | |
+20.12% | 125B | |
+21.32% | 114B | |
+25.56% | 26.73B | |
-23.42% | 19.43B | |
-18.10% | 16.22B | |
-18.96% | 15.33B | |
+9.24% | 14.42B | |
-48.41% | 14.33B | |
+56.65% | 14.2B |
- Stock Market
- Equities
- OBSEF Stock
- Company ObsEva SA